Literature DB >> 33411192

Imaging and depression in multiple sclerosis: a historical perspective.

Fabio Giuseppe Masuccio1, Giulia Gamberini1, Massimiliano Calabrese2, Claudio Solaro3.   

Abstract

PURPOSE: Patients affected with multiple sclerosis suffer from depression more frequently than the general population. Beyond psychosocial, genetic and immune-inflammatory factors, also the brain damage which is peculiar of multiple sclerosis has been claimed to have a role in the aetiology of depression in those patients. The study of this interesting relation has been implemented with both conventional and advanced magnetic resonance imaging techniques. The aim of this review is to provide a historical perspective on the link between multiple sclerosis-related depression and structural and functional brain damage.
METHODS: In this review, the results of the MRI studies regarding multiple sclerosis-related brain damage and the presence of depression are presented.
RESULTS: The findings of the reports reveal a link between brain pathology and depressive symptoms or the diagnosis of depression in multiple sclerosis.
CONCLUSIONS: Although a multifactorial aetiology has been theorized for depression and depressive symptoms in patients with multiple sclerosis, this review supports the hypothesis that the structural and functional brain impairment might substantially be amongst those factors. Thus, depression itself might be a symptom with a neuro-biological basis and not only the consequence of the disability derived from the neurological impairment.

Entities:  

Keywords:  Depression; Depressive symptoms; Magnetic resonance imaging; Multiple sclerosis

Mesh:

Substances:

Year:  2021        PMID: 33411192     DOI: 10.1007/s10072-020-04951-z

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  20 in total

Review 1.  Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis--establishing disease prognosis and monitoring patients.

Authors:  Mike P Wattjes; Àlex Rovira; David Miller; Tarek A Yousry; Maria P Sormani; Maria P de Stefano; Mar Tintoré; Cristina Auger; Carmen Tur; Massimo Filippi; Maria A Rocca; Franz Fazekas; Ludwig Kappos; Chris Polman
Journal:  Nat Rev Neurol       Date:  2015-09-15       Impact factor: 42.937

2.  Lesion pattern in patients with multiple sclerosis and depression.

Authors:  D Berg; T Supprian; J Thomae; M Warmuth-Metz; A Horowski; B Zeiler; T Magnus; P Rieckmann; G Becker
Journal:  Mult Scler       Date:  2000-06       Impact factor: 6.312

3.  Immune-Inflammatory and Oxidative and Nitrosative Stress Biomarkers of Depression Symptoms in Subjects with Multiple Sclerosis: Increased Peripheral Inflammation but Less Acute Neuroinflammation.

Authors:  Ana Paula Kallaur; Josiane Lopes; Sayonara Rangel Oliveira; Andrea Name Colado Simão; Edna Maria Vissoci Reiche; Elaine Regina Delicato de Almeida; Helena Kaminami Morimoto; Wildea Lice Carvalho Jennings de Pereira; Daniele Frizon Alfieri; Sueli Donizete Borelli; Domacio Ramon Kaimen-Maciel; Michael Maes
Journal:  Mol Neurobiol       Date:  2015-09-24       Impact factor: 5.590

4.  Involvement of the limbic system in multiple sclerosis patients with depressive disorders.

Authors:  U Sabatini; C Pozzilli; P Pantano; T Koudriavtseva; A Padovani; E Millefiorini; C Di Biasi; G F Gualdi; M Salvetti; G L Lenzi
Journal:  Biol Psychiatry       Date:  1996-06-01       Impact factor: 13.382

5.  Psychiatric morbidity in multiple sclerosis: a clinical and MRI study.

Authors:  M A Ron; S J Logsdail
Journal:  Psychol Med       Date:  1989-11       Impact factor: 7.723

6.  Lesions in the left arcuate fasciculus region and depressive symptoms in multiple sclerosis.

Authors:  J Pujol; J Bello; J Deus; J L Martí-Vilalta; A Capdevila
Journal:  Neurology       Date:  1997-10       Impact factor: 9.910

7.  Correlates of cognitive impairment and depressive mood disorder in multiple sclerosis.

Authors:  A Möller; G Wiedemann; U Rohde; H Backmund; A Sonntag
Journal:  Acta Psychiatr Scand       Date:  1994-02       Impact factor: 6.392

8.  Temporal lobe involvement in multiple sclerosis patients with psychiatric disorders.

Authors:  W G Honer; T Hurwitz; D K Li; M Palmer; D W Paty
Journal:  Arch Neurol       Date:  1987-02

Review 9.  Systematic review of depression in patients with multiple sclerosis and its relationship to interferonβ treatment.

Authors:  Leila Alba Palé; Jordi León Caballero; Berta Samsó Buxareu; Purificación Salgado Serrano; Víctor Pérez Solà
Journal:  Mult Scler Relat Disord       Date:  2017-07-12       Impact factor: 4.339

Review 10.  Depression in Multiple Sclerosis: Epidemiology, Aetiology, Diagnosis and Treatment.

Authors:  Claudio Solaro; Giulia Gamberini; Fabio Giuseppe Masuccio
Journal:  CNS Drugs       Date:  2018-02       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.